Search results
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people's bodies and their self-belief by using technology to take the limits off living.
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. [8]
Find out more about careers and culture at Smith+Nephew, including inclusion, diversity and equity, wellbeing, flexibility and benefits, and our current vacancies.
View Options. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. The content on this website may not be approved for use in your specific region or country.
Smith+Nephew | 574,269 followers on LinkedIn. We design and manufacture technology that takes the limits off living. | Smith+Nephew is a global medical technology company.
Jul 4, 2024 · Activist investor Cevian Capital has disclosed a stake in Smith & Nephew, sending shares in the London-listed manufacturer of medical devices up more than 7 per cent.
About us. Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their...
Apr 11, 2024 · Smith & Nephew shareholders have been urged to vote against an “excessive” pay rise of almost 30 per cent for the US-based boss of the FTSE 100 industrial group, the latest salvo in the battle...
Jul 16, 2024 · Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today ...
Feb 12, 2024 · Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024.
